These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37383713)

  • 1. A tricarboxylic acid cycle-based machine learning model to select effective drug targets for the treatment of esophageal squamous cell carcinoma.
    Liang Y; Tan B; Du M; Wang B; Gao Y; Wang M
    Front Pharmacol; 2023; 14():1195195. PubMed ID: 37383713
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
    Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y
    Front Oncol; 2021; 11():769727. PubMed ID: 34926275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Epithelial-Mesenchymal Transition- (EMT-) Related LncRNA for Prognostic Prediction and Risk Stratification in Esophageal Squamous Cell Carcinoma.
    Wang P; Chen Y; Zheng Y; Fu Y; Ding Z
    Dis Markers; 2021; 2021():5340240. PubMed ID: 34712369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel immune-related gene signature predicts survival in esophageal squamous cell carcinoma.
    Xu T; Dai T; Zeng P; Guo Y; He K
    Transl Cancer Res; 2021 May; 10(5):2354-2367. PubMed ID: 35116551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial heterogeneity and Immune infiltration of cellular lysosomal pathways reveals a new blueprint for tumor heterogeneity in esophageal cancer.
    Wei J; Wu X; Wang S; Liu S; Gao X
    Front Endocrinol (Lausanne); 2023; 14():1138457. PubMed ID: 37091857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer.
    Ren Q; Zhang P; Zhang X; Feng Y; Li L; Lin H; Yu Y
    Front Immunol; 2023; 14():1199040. PubMed ID: 37313409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Risk Models Using Epithelial Cells Identify β-Sitosterol as a Potential Therapeutic Target Against Esophageal Squamous Cell Carcinoma.
    Zhang Z; Shang B; Mao X; Shi Y; Zhang G; Wang D
    Int J Gen Med; 2024; 17():1193-1211. PubMed ID: 38559590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer.
    Zhang Z; Wang J; Han W; Zhao L
    BMC Gastroenterol; 2023 Apr; 23(1):132. PubMed ID: 37081402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel immune-related radioresistant lncRNAs signature based model for risk stratification and prognosis prediction in esophageal squamous cell carcinoma.
    Zheng J; Chen X; Huang B; Li J
    Front Genet; 2022; 13():921902. PubMed ID: 36147506
    [No Abstract]   [Full Text] [Related]  

  • 11. Exploring the Potential of Exosome-Related LncRNA Pairs as Predictors for Immune Microenvironment, Survival Outcome, and Microbiotain Landscape in Esophageal Squamous Cell Carcinoma.
    Zhao F; Li Z; Dong Z; Wang Z; Guo P; Zhang D; Li S
    Front Immunol; 2022; 13():918154. PubMed ID: 35880180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel pyroptosis-related model for prognostic prediction in esophageal squamous cell carcinoma: a bioinformatics analysis.
    Shi Q; Liu M; Wang S; Ding P; Wang Y
    J Thorac Dis; 2023 Mar; 15(3):1387-1397. PubMed ID: 37065557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A demonstration based on multi-omics transcriptome sequencing data revealed disulfidptosis heterogeneity within the tumor microenvironment of esophageal squamous cell carcinoma.
    Liu F; Yuan D; Liu X; Zhuo S; Liu X; Sheng H; Sha M; Ye J; Yu H
    Discov Oncol; 2023 Jun; 14(1):96. PubMed ID: 37306828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weighted Correlation Network Analysis of Cancer Stem Cell-Related Prognostic Biomarkers in Esophageal Squamous Cell Carcinoma.
    Zhao M; Jin X; Chen Z; Zhang H; Zhan C; Wang H; Wang Q
    Technol Cancer Res Treat; 2022; 21():15330338221117003. PubMed ID: 35899307
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
    Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
    Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and Evaluation of a Risk Score Model for Lymph Node Metastasis-Associated Circadian Clock Genes in Esophageal Squamous Carcinoma.
    Cheng J; Chen F; Cheng Y
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
    Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
    Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of TREM2-positive tumor-associated macrophages in esophageal squamous cell carcinoma: implication for poor prognosis and immunotherapy modulation.
    Li H; Miao Y; Zhong L; Feng S; Xu Y; Tang L; Wu C; Zhang X; Gu L; Diao H; Wang H; Wen Z; Yang M
    Front Immunol; 2023; 14():1162032. PubMed ID: 37187751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a prognostic nomogram based on an eight-gene signature for esophageal squamous cell carcinoma by weighted gene co-expression network analysis (WGCNA).
    Xie J; Yang P; Wei H; Mai P; Yu X
    Ann Transl Med; 2022 Jan; 10(2):88. PubMed ID: 35282133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic role of FZD6 in esophageal squamous cell carcinoma patients.
    Zhang J; Wang JL; Zhang CY; Ma YF; Zhao R; Wang YY
    Clin Transl Oncol; 2020 Jul; 22(7):1172-1179. PubMed ID: 31748958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.